Issue link: https://viewer.e-digitaledition.com/i/745482
INFORMED BY THE FIRST NATIONAL SURVEY OF PREGNANT WOMEN AND THEIR MEDICAL PROVIDERS, AN IMPORTANT FREE RESOURCE WILL SOON BE AVAILABLE TO PREGNANT WOMEN, MEDICAL CARE PROVIDERS, AND NATIONAL AND LOCAL DOWN SYNDROME ORGANIZATIONS. THE NATIONAL DOWN Syndrome Congress (NDSC) and the Global Down Syndrome Foundation co-published the first edition of the Prenatal Testing Pamphlet for Down Syndrome in 2013. The new version of the pamphlet, Prenatal Testing & Information About Down Syndrome, will be released Nov. 20 and will feature up-to- date information about testing, statistics, and resources designed to empower pregnant women and their families. "We are proud to be co-publishing this new resource with Global," said David Tolleson, Executive Director of NDSC. "It is an excellent supplement to several existing resources in that it not only has current, accurate, and easily digestible information, but it is also in the form of a simple pamphlet and free both online and in print." The deeply personal choice of whether or not to participate in prenatal testing can be a milestone during pregnancy. If a patient decides to take part, understanding the results adds another layer of complexity. A vital resource for anyone who is considering, or has just had, prenatal testing for Down syndrome, the new pamphlet can help alleviate confusion and anxiety around this pivotal point by providing pregnant women with the current, accurate, and easy-to-understand information they need. UPDATES WITH PHILOSOPHICAL CONSISTENCY Top scientists and clinicians contributed to the second edition of the pamphlet, updating information about screening and diagnostic tests, adding information about resources, and providing an annotated list of diseases that people with Down syndrome are both predisposed to and, equally important, protected from. In response to the important input from more than 400 pregnant women, this version incorporates more photos, more inclusive language, and clear, concise language throughout. Current recommendations from the American Congress of Obstetricians and Gynecologists and other professional societies are also covered, including guidance on who should be offered specific tests, such as the noninvasive cell-free DNA test (cfDNA), which was recently classified as a screening, not diagnostic, test. "NDSC is such a wonderful, nurturing national organization, and they have been key to developing this second edition," said Michelle Sie Whitten, President and CEO of Global. "Armed with the results of the national survey, NDSC's Professional Advisory Council helped us think through difficult A New Prenatal Testing Pamphlet for Down Syndrome Get the Facts: Get the Facts: FALL2016 DOWN SYNDROME WORLD 26

